This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our privacy statement for more information on the cookies we use and how to delete or block them.
  • Acquisition of Albyn Medical SL by Creo Medical PLC

Acquisition of Albyn Medical SL by Creo Medical PLC

Deal TypeTransaction Services
IndustryHealthcare
ClientCreo Medical Group Plc

BDO provided financial and tax due diligence services to Creo Medical Group plc in relation to its acquisition of Albyn Medical. 

Creo Medical Group plc is a medical device company focused on the emerging field of surgical endoscopy. Albyn Medical is a European specialist in the supply and manufacture of Gastroenterology, Urology and Endoscopy products to healthcare providers. 

The acquisition of Albyn Medical fits with the strategy set out by Creo at the time of its fundraising last year and provides it with a commercial and distribution platform to accelerate the development of its business in Europe. Albyn Medical focuses on gastrointestinal (“GI”) products and the acquisition provides a direct route-to-market for Creo’s full suite of CE marked GI advanced energy devices.

"BDO fielded an experienced, collaborative and integrated team, drawing on their European offices to support us in a clear, responsive and direct way throughout the transaction, and helping to conclude the deal in an efficient manner."
Tony Trussell, Creo Medical Corporate Development Officer